{"schema_version":"secwatch.filing_event.v1","accession":"0001299130-24-000200","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2024-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.011454+00:00","generated_at":"2026-05-29T03:21:48.842368+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pacific Biosciences amends CEO/COO severance: lump sum 12-18 months salary, extended change-of-control window","bullets":["CEO Christian Henry receives lump sum cash severance equal to 18 months of base salary.","COO Mark Van Oene receives lump sum cash severance equal to 12 months of base salary.","Change-of-control period expanded to include 3 months prior to a change in control.","Company also amended and restated the form change-in-control agreement for all executive officers."],"urls":{"canonical":"https://secwatch.observer/filing/0001299130-24-000200","json":"https://secwatch.observer/filing/0001299130-24-000200.json","markdown":"https://secwatch.observer/filing/0001299130-24-000200.md","text":"https://secwatch.observer/filing/0001299130-24-000200.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000200/0001299130-24-000200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000200/pacb-20241211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:21:48.842368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}